AMG 181

Enfortumab vedotin

Immunoglobulin [1-aspartic acid], anti-(human respiratory syncytial virus fusion protein) (Lama glama heavy chain variable region fragment) fusion protein with peptide (synthetic 15-amino acid linker) fusion protein with immunoglobulin anti-(human respiratory syncytial virus fusion protein) (Lama glama heavy chain variable region fragment) fusion protein with peptide (synthetic 15-amino acid linker) fusion protein with immunoglobulin anti-(human respiratory syncytial virus fusion protein) (Lama glama heavy chain variable region fragment) (ACI)

DNA d(P-thio)(T-C-G-T-C-G-T-T-T-T-C-G-C-G-C-G-C-G-C-C-G) (ACI)

3-36-Peptide YY

Orticumab

C.I. Solvent Red 27 (7CI, 8CI)

(16E)-14-Methyl-20-oxa-5,7,14,27-tetraazatetracyclo[19.3.1.12,6.18,12]heptacosa-1(25),2,4,6(27),8,10,12(26),16,21,23-decaene (ACI)

GSK 249320 (ACI)

Ozoralizumab

Ublituximab

Vesencumab

Immunoglobulin G1, anti-(human protein TEM1 (tumor endothelial marker 1)) (human-mouse monoclonal MORAb-004 heavy chain), disulfide with human-mouse monoclonal MORAb-004 κ-chain, dimer (ACI)

Immunoglobulin, anti-(human glycoprotein NMB extracellular domain) (human monoclonal CR011 heavy chain), disulfide with human monoclonal CR011 κ-chain, dimer (ACI)

Filipin (7CI, 8CI, 9CI, ACI)

(-)-Oligomycin C

Teprotumumab

Olaratumab

4H-Cyclopenta[a]cyclopropa[f]cycloundecen-4-one, 1,1a,4a,5,6,7,7a,8,11,11a-decahydro-4a,7,8-trihydroxy-9-(hydroxymethyl)-1,1,3,6-tetramethyl-, [1aR-(1aR*,2E,4aR*,6S*,7S*,7aS*,8S*,9Z,11aS*)]- (9CI)

Immunoglobulin G1, anti-(rabies virus glycoprotein) (human monoclonal CR4098 heavy chain), disulfide with human monoclonal CR4098 κ-chain, dimer (ACI)